$JRSS
JRSIS HEALTH CARE Corp Stock $jrss

$jrss Overview Financials Valuation SEC Filings Company Website

2014 Form 10-K Financial Statement

#000114420415020283 Filed on March 31, 2015

Income Statement

Concept	2014	2013
Revenue	$5.980M	$4.351M
YoY Change	37.42%	25.04%
Cost Of Revenue	$1.735M	$1.248M
YoY Change	39.06%	21.16%
Gross Profit	$4.244M	$3.103M
YoY Change	36.77%	26.67%
Gross Profit Margin	70.98%	71.32%
Selling, General & Admin	$1.489M	$1.160M
YoY Change	28.4%	38.1%
% of Gross Profit	35.09%	37.38%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$175.3K	$116.4K
YoY Change	50.63%	29.31%
% of Gross Profit	4.13%	3.75%
Operating Expenses	$2.315M	$1.770M
YoY Change	30.78%	37.21%
Operating Profit	$918.0K	$1.318M
YoY Change	-30.34%	13.61%
Interest Expense	$1.011M	$12.77K
YoY Change	7823.82%	-227.65%
% of Operating Profit	110.19%	0.97%
Other Income/Expense, Net	$25.30K	$10.00K
YoY Change	153.0%
Pretax Income	$943.3K	$1.325M
YoY Change	-28.79%	15.19%
Income Tax	$2.157K	$1.984K
% Of Pretax Income	0.23%	0.15%
Net Earnings	$611.5K	$400.0K
YoY Change	52.88%
Net Earnings / Revenue	10.23%	9.19%
Basic Earnings Per Share	$0.05	$0.29
Diluted Earnings Per Share	$0.05	$0.29
COMMON SHARES
Basic Shares Outstanding	13.49M shares	1.381M shares
Diluted Shares Outstanding	13.49M shares	1.381M shares

Balance Sheet

Concept	2014	2013 Q4	2013
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.046M		$630.0K
YoY Change	66.11%		215.0%
Cash & Equivalents	$1.046M	$631.3K	$630.0K
Short-Term Investments
Other Short-Term Assets	$784.4K		$80.00K
YoY Change	880.54%		14.29%
Inventory	$180.6K	$98.30K	$100.0K
Prepaid Expenses		$61.57K
Receivables	$661.7K	$271.4K	$270.0K
Other Receivables	$187.1K	$2.699K	$190.0K
Total Short-Term Assets	$2.860M	$1.266M	$1.270M
YoY Change	125.23%		135.19%
LONG-TERM ASSETS
Property, Plant & Equipment	$20.33M	$1.417M	$16.76M
YoY Change	21.31%		1496.19%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$677.0K		$490.0K
YoY Change	38.17%		2350.0%
Total Long-Term Assets	$21.01M	$17.25M	$17.25M
YoY Change	21.79%		1512.15%
TOTAL ASSETS
Total Short-Term Assets	$2.860M	$1.266M	$1.270M
Total Long-Term Assets	$21.01M	$17.25M	$17.25M
Total Assets	$23.87M	$18.52M	$18.52M
YoY Change	28.88%		1050.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$291.1K	$84.47K	$80.00K
YoY Change	263.88%		60.0%
Accrued Expenses	$30.81K		$30.00K
YoY Change	2.7%		-25.0%
Deferred Revenue
YoY Change
Short-Term Debt	$1.768M	$0.00	$0.00
YoY Change			-100.0%
Long-Term Debt Due	$807.5K		$210.0K
YoY Change	284.51%		50.0%
Total Short-Term Liabilities	$2.976M	$350.7K	$350.0K
YoY Change	750.22%		-33.96%
LONG-TERM LIABILITIES
Long-Term Debt	$15.90M		$15.02M
YoY Change	5.88%		21357.14%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$15.90M		$15.02M
YoY Change	5.88%		21357.14%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.976M	$350.7K	$350.0K
Total Long-Term Liabilities	$15.90M		$15.02M
Total Liabilities	$21.88M	$15.37M	$18.05M
YoY Change	21.19%		1021.12%
SHAREHOLDERS EQUITY
Retained Earnings		$400.0K
YoY Change
Common Stock		$50.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.994M	$473.8K	$470.0K
YoY Change
Total Liabilities & Shareholders Equity	$23.87M	$18.52M	$18.52M
YoY Change	28.88%		1050.31%

Cashflow Statement

Concept	2014	2013
OPERATING ACTIVITIES
Net Income	$611.5K	$400.0K
YoY Change	52.88%
Depreciation, Depletion And Amortization	$175.3K	$116.4K
YoY Change	50.63%	29.31%
Cash From Operating Activities	$2.054M	$990.0K
YoY Change	107.49%	-27.74%
INVESTING ACTIVITIES
Capital Expenditures	$3.593M	$701.5K
YoY Change	412.24%	-2438.35%
Acquisitions
YoY Change
Other Investing Activities	$65.06K	$100.0K
YoY Change	-34.94%	900.0%
Cash From Investing Activities	-$4.180M	-$650.0K
YoY Change	543.1%	2066.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$918.3K	$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.537M	80.00K
YoY Change	3071.73%	-106.35%
NET CHANGE
Cash From Operating Activities	2.054M	990.0K
Cash From Investing Activities	-4.180M	-650.0K
Cash From Financing Activities	2.537M	80.00K
Net Change In Cash	411.4K	420.0K
YoY Change	-2.04%	425.0%
FREE CASH FLOW
Cash From Operating Activities	$2.054M	$990.0K
Capital Expenditures	$3.593M	$701.5K
Free Cash Flow	-$1.539M	$288.5K
YoY Change	-633.52%	-79.39%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2014	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	631288	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1046485	USD
CY2013Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	271427	USD
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	661665	USD
CY2013Q4	us-gaap	Inventory Net InventoryNet	98300	USD
CY2014Q4	us-gaap	Inventory Net InventoryNet	180630	USD
CY2013Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	2699	USD
CY2014Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1755	USD
CY2013Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	61572	USD
CY2014Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	691802	USD
CY2013Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	180930	USD
CY2014Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	185391	USD
CY2013Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	19300	USD
CY2014Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	92630	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	1265516	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	2860358	USD
CY2013Q4	cik0001597892	Construction In Progress ConstructionInProgress	15346873	USD
CY2014Q4	cik0001597892	Construction In Progress ConstructionInProgress	0	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1416732	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	20331864	USD
CY2013Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	490677	USD
CY2014Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	677013	USD
CY2013Q4	us-gaap	Assets Assets	18519798	USD
CY2014	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2014	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
CY2014	dei	Entity Registrant Name EntityRegistrantName	JRSIS HEALTH CARE Corp
CY2014	dei	Document Type DocumentType	10-K
CY2014	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2014	dei	Entity Central Index Key EntityCentralIndexKey	0001597892
CY2014	dei	Amendment Flag AmendmentFlag	false
CY2014	dei	Document Period End Date DocumentPeriodEndDate	2014-12-31
CY2014Q4	us-gaap	Assets Assets	23869235	USD
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	84469	USD
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	291097	USD
CY2013Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	0	USD
CY2014Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	471277	USD
CY2013Q4	us-gaap	Deposit Liability Current DepositLiabilityCurrent	9208	USD
CY2014Q4	us-gaap	Deposit Liability Current DepositLiabilityCurrent	6526	USD
CY2013Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	0	USD
CY2014Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	1297036	USD
CY2013	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	0	USD
CY2014	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	0	USD
CY2013Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	18569	USD
CY2014Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	71562	USD
CY2013Q4	us-gaap	Loss Contingency Estimate Of Possible Loss LossContingencyEstimateOfPossibleLoss	0	USD
CY2014Q4	us-gaap	Loss Contingency Estimate Of Possible Loss LossContingencyEstimateOfPossibleLoss	0	USD
CY2013Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	26975	USD
CY2014Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	30808	USD
CY2013Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	211459	USD
CY2014Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	807478	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	350680	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2975784	USD
CY2013Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	15024218	USD
CY2014Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	15903211	USD
CY2013Q4	us-gaap	Liabilities Liabilities	15374898	USD
CY2014Q4	us-gaap	Liabilities Liabilities	18878995	USD
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	12000	USD
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	13604	USD
CY2013Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	38000	USD
CY2014Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	954686	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	399977	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1011471	USD
CY2013Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	23859	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	14045	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	473836	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	1993806	USD
CY2013Q4	us-gaap	Minority Interest MinorityInterest	2671064	USD
CY2014Q4	us-gaap	Minority Interest MinorityInterest	2996434	USD
CY2013Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3144900	USD
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4990240	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18519798	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	23869235	USD
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12000000	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13604000	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12000000	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13604000	shares
CY2013	us-gaap	Net Income Loss NetIncomeLoss	399977	USD
CY2014	us-gaap	Net Income Loss NetIncomeLoss	611494	USD
CY2013	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1380822	shares
CY2014	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13494129	shares
CY2013	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2014	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2013	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1380822	shares
CY2014	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13494129	shares
CY2013	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.2897
CY2014	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.0453
CY2013	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.2897
CY2014	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.0453
CY2013	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	2084492	USD
CY2014	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	2937981	USD
CY2013	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	2266744	USD
CY2014	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	3041629	USD
CY2013	us-gaap	Sales Revenue Net SalesRevenueNet	4351236	USD
CY2014	us-gaap	Sales Revenue Net SalesRevenueNet	5979610	USD
CY2013	us-gaap	Cost Of Goods Sold CostOfGoodsSold	1247915	USD
CY2014	us-gaap	Cost Of Goods Sold CostOfGoodsSold	1735300	USD
CY2013	cik0001597892	Cost Of Medical Consumables CostOfMedicalConsumables	307493	USD
CY2014	cik0001597892	Cost Of Medical Consumables CostOfMedicalConsumables	451394	USD
CY2013	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	890780	USD
CY2014	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	1176798	USD
CY2013	us-gaap	Supplies Expense SuppliesExpense	65472	USD
CY2014	us-gaap	Supplies Expense SuppliesExpense	100998	USD
CY2013	us-gaap	Shipping Handling And Transportation Costs ShippingHandlingAndTransportationCosts	60353	USD
CY2014	us-gaap	Shipping Handling And Transportation Costs ShippingHandlingAndTransportationCosts	35348	USD
CY2013	us-gaap	Utilities Costs UtilitiesCosts	67474	USD
CY2014	us-gaap	Utilities Costs UtilitiesCosts	62367	USD
CY2013	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	165667	USD
CY2014	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	153568	USD
CY2013	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	5344	USD
CY2014	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	2651	USD
CY2013	us-gaap	Interest Expense InterestExpense	12765	USD
CY2014	us-gaap	Interest Expense InterestExpense	1011476	USD
CY2013	us-gaap	Professional Fees ProfessionalFees	93776	USD
CY2014	us-gaap	Professional Fees ProfessionalFees	156444	USD
CY2013	us-gaap	Depreciation Depreciation	116378	USD
CY2014	us-gaap	Depreciation Depreciation	175303	USD
CY2013	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	3033417	USD
CY2014	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	5061647	USD
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	1317819	USD
CY2014	us-gaap	Operating Income Loss OperatingIncomeLoss	917963	USD
CY2013	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	6857	USD
CY2014	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	25299	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1324676	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	943262	USD
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1984	USD
CY2014	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2157	USD
CY2013	us-gaap	Profit Loss ProfitLoss	1322692	USD
CY2014	us-gaap	Profit Loss ProfitLoss	941105	USD
CY2013	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	922715	USD
CY2014	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	329611	USD
CY2013	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	37927	USD
CY2014	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	-4241	USD
CY2013	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	23859	USD
CY2014	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-9814	USD
CY2013	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	1384478	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	927050	USD
CY2013	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	960642	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	325370	USD
CY2013	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	423836	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	601680	USD
CY2013	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.2897
CY2013	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	1380822	shares
CY2014	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	13494129	shares
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	993214	USD
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	2054183	USD
CY2013	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	701504	USD
CY2014	us-gaap	Use Of Estimates UseOfEstimates	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"></div> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="top" width="5%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><i><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> C.</font></i></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 95%; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="top" width="95%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><i><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Use of estimates</font></i></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">  </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">The preparation of audited consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting periods. Management makes these estimates using the best information available at the time the estimates are made; however actual results could differ from those estimates. Significant items subject to such estimates and assumptions include valuation allowances for receivables and recoverability of carrying amount and the estimated useful lives of long-lived assets. These estimates are often based on complex judgments and assumptions that management believes to be reasonable but are inherently uncertain and unpredictable. Actual results could differ from these estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"></div> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; WIDTH: 5%; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="top" width="5%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><i><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> E.</font></i></div> </td> <td style="BORDER-BOTTOM: #d4d0c8; BORDER-LEFT: #d4d0c8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; WIDTH: 95%; PADDING-RIGHT: 0in; BORDER-TOP: #d4d0c8; BORDER-RIGHT: #d4d0c8; PADDING-TOP: 0in" valign="top" width="95%"> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><i><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Concentration of Credit Risk</font></i></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">  </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk are cash, accounts receivable and other receivables arising from its normal business activities. The Company places its cash in what it believes to be credit-worthy financial institutions. The Company has a diversified customer base. The majority of sales are either cash receipt in advance or cash receipt upon delivery. For the years ended December 31, 2014 and December 31, 2013 respectively no and no customer accounted for more than 10% of net revenue. As of December 31, 2014 and December 31, 2013 respectively 1 and 1 customer accounted for more than <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 5</font></font>% of net accounts receivable. For those credit sales, the Company routinely assesses the financial strength of its customers and, based upon factors surrounding the credit risk, establishes an allowance, if required, for uncollectible accounts and, as a consequence, believes that its accounts receivable credit risk exposure beyond such allowance is limited.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2013	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-417976	USD
CY2014	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	178700	USD
CY2013	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	3000	USD
CY2014	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	-2625	USD
CY2013	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-18692	USD
CY2014	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	7003	USD
CY2012Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1007914	USD
CY2013	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	702508	USD
CY2013	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	50000	USD
CY2014	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	918290	USD
CY2013Q4	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	61786	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-14055	USD
CY2013	us-gaap	Interest Expense Other InterestExpenseOther	0	USD
CY2014	us-gaap	Interest Expense Other InterestExpenseOther	1007743	USD
CY2013	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-5959	USD
CY2014	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	15363	USD
CY2013	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	57653	USD
CY2014	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	392318	USD
CY2013	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	35360	USD
CY2014	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	83033	USD
CY2013	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-37843	USD
CY2014	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-20982	USD
CY2013	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	37023	USD
CY2014	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	216686	USD
CY2014	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3593370	USD
CY2013	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.25	pure
CY2014	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.25	pure
CY2013	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	42916	USD
CY2014	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	651816	USD
CY2013	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	95351	USD
CY2014	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	65060	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-649069	USD
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-4180126	USD
CY2013	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	702670	USD
CY2014	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	0	USD
CY2013	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2014	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	918290	USD
CY2013	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	627659	USD
CY2014	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	1593231	USD
CY2013	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	USD
CY2014	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	1114145	USD
CY2013	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	0	USD
CY2014	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	471682	USD
CY2013	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	0	USD
CY2014	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	1626490	USD
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	75011	USD
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	2537376	USD
CY2014	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	415197	USD
CY2013	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	11657	USD
CY2014	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	3764	USD
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	430813	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	200475	USD
CY2013	us-gaap	Income Taxes Paid IncomeTaxesPaid	-1984	USD
CY2014	us-gaap	Income Taxes Paid IncomeTaxesPaid	-2157	USD
CY2013	us-gaap	Interest Paid InterestPaid	-11539	USD
CY2014	us-gaap	Interest Paid InterestPaid	-1007743	USD
CY2013	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	15185032	USD
CY2014	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	269765	USD
CY2013Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	298823	USD
CY2014Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	688885	USD
CY2013Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	27396	USD
CY2014Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	27220	USD
CY2014Q4	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	736771	USD
CY2014Q4	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	807478	USD
CY2014Q4	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	829630	USD
CY2014Q4	us-gaap	Capital Leases Future Minimum Payments Due Thereafter CapitalLeasesFutureMinimumPaymentsDueThereafter	14336810	USD
CY2014Q4	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	16710689	USD
CY2014Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	0	USD
CY2014Q4	us-gaap	Short Term Debt Percentage Bearing Fixed Interest Rate ShortTermDebtPercentageBearingFixedInterestRate	0.0784	pure
CY2013	us-gaap	Interest Expense Debt InterestExpenseDebt	0	USD
CY2014	us-gaap	Interest Expense Debt InterestExpenseDebt	1644	USD
CY2014Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	20864591	USD
CY2013Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1804010	USD
CY2013Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	387277	USD
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	532727	USD
CY2014	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2013-11-20
CY2014Q4	us-gaap	Capital Leases Net Investment In Direct Financing Leases CapitalLeasesNetInvestmentInDirectFinancingLeases	1007743	USD
CY2013Q4	us-gaap	Capital Leases Net Investment In Direct Financing Leases CapitalLeasesNetInvestmentInDirectFinancingLeases	10661	USD
	cik0001597892	Business Acquisition Equity Interest Acquired Number Of Shares BusinessAcquisitionEquityInterestAcquiredNumberOfShares	50000	shares

Files In Submission

Name	View Source	Status
0001144204-15-020283-index-headers.html	Edgar Link	pending
0001144204-15-020283-index.html	Edgar Link	pending
0001144204-15-020283.txt	Edgar Link	pending
0001144204-15-020283-xbrl.zip	Edgar Link	pending
chartpg5.jpg	Edgar Link	pending
cik0001597892-20141231.xml	Edgar Link	completed
cik0001597892-20141231.xsd	Edgar Link	pending
cik0001597892-20141231_cal.xml	Edgar Link	unprocessable
cik0001597892-20141231_def.xml	Edgar Link	unprocessable
cik0001597892-20141231_lab.xml	Edgar Link	unprocessable
cik0001597892-20141231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tlogo.jpg	Edgar Link	pending
tlogof1.jpg	Edgar Link	pending
v405465_10k.htm	Edgar Link	pending
v405465_ex31-1.htm	Edgar Link	pending
v405465_ex31-2.htm	Edgar Link	pending
v405465_ex32-1.htm	Edgar Link	pending
v405465_ex32-2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$JRSS
JRSIS HEALTH CARE Corp Stock $jrss

2014 Form 10-K Financial Statement

#000114420415020283 Filed on March 31, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JRSS JRSIS HEALTH CARE Corp Stock $jrss

2014 Form 10-K Financial Statement

#000114420415020283 Filed on March 31, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JRSS
JRSIS HEALTH CARE Corp Stock $jrss